Editas Medicine, Inc.
EDIT
$2.22
-$0.13-5.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -67.61% | 26.95% | 8.08% | -9.13% | -228.23% |
| Total Depreciation and Amortization | 38.81% | -13.63% | 12.61% | 0.78% | -3.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 63.65% | 48.02% | 33.15% | -53.74% | 80.31% |
| Change in Net Operating Assets | 245.59% | -378.84% | -32.31% | 33.54% | 159.35% |
| Cash from Operations | 5.84% | 3.47% | 7.84% | -14.42% | -124.24% |
| Capital Expenditure | 78.89% | 81.51% | 16.40% | -86.75% | -43.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 79.38% | -63.75% | 56.72% | 2,029.30% | -104.48% |
| Cash from Investing | 82.14% | -63.14% | 61.64% | 1,194.92% | -107.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 433.46% | -- | -100.00% | 67.71% | -62.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -105.20% | -- | -- | -- | -- |
| Cash from Financing | -102.59% | -- | -100.00% | 67.71% | -62.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.97% | 13.76% | 755.89% | 91.21% | -232.38% |